CD8A and neoplasm: or C. kwangsiensis S. G. Lee et C. F. Liang or C. wenyujin Y. H. Chen et C. Ling), triggered the inhibition of tumor angiogenesis via restricting HIF-1α/VEGFA release, recuperated the immunity with the enhancement of CD8+ T and Treg cells, TNF-α level, and the abatement of IL-6 in lung cancer-bearing mice (Sun et al., 2021).